Dystrophin quantification: biological and translational research implications

Karen Anthony, Virginia Arechavala-Gomeza, Laura E Taylor, Adeline Vulin, Yuuki Kaminoh, Silvia Torelli, Lucy Feng, Narinder Janghra, Gisele Bonne, Maud Beuvin, Rita Barresi, Matt Henderson, Steven Laval, Afrodite Lourbakos, Giles Campion, Volker Straub, Thomas Voit, Caroline A Sewry, Jennifer E Morgan, Kevin M FlaniganFrancesco Muntoni

Research output: Contribution to JournalArticle

Impacts

FDA approves first drug to treat Duchenne muscular dystrophy (DMD)

Karen Anthony (Co-Investigator)

Impact: Public policy impacts, Health and Well-Being impacts, Quality of life impacts, 03: Good Health and Well-Being (UN SDG)